CrossRef Cardiac Autonomic Neuropathy in Type 1 and 2 Diabetes: Epidemiology, Pathophysiology, and Management Scott Williams, Siddig Abdel Raheim, Muhammad Ilyas Khan, Umme Rubab, Prathap Kanagala, Sizheng Steven Zhao, Anne Marshall, Emily Brown, Uazman Alam Clinical Therapeutics.2022
Jankowski J, Floege J, Fliser D, Bohm M, Marx N
Wang W, Liu G, Zheng J
We can combine peptide therapy with GLP-1 treatments to enhance patients wellness journeys and provide them with the best results
Well begin with a detailed consultation to understand your health background and weight loss goals
Incretin-based therapy and risk of cholangiocarcinoma: a nested case-control study in a population of subjects with type 2 diabetes